Abstract
Diarrhea is the third leading cause of malnutrition and mortality in children under five globally. However, a few studies have examined predictors of child diarrheal disease in arid or semi-arid regions of sub-Saharan Africa. This study aimed to assess the prevalence and risk factors of diarrhea among children under five in the drylands of Northern Kenya.
Data are from a longitudinal, population-based study of children younger than 36 months at recruitment (N = 1,211) and their caregivers in Turkana County, Kenya. Households were followed from May 2021 to September 2023, with survey data collected every four months across six waves. Caregivers reported on household conditions and observed episodes of diarrhea among index children in the two weeks before the survey. Trends in the prevalence of diarrhea were stratified by administrative zone, livelihood zone, and child sex. Risk factors of child diarrhea across survey waves were identified using multivariable generalized estimating equations.
Diarrhea prevalence decreased from 32.1% [95% confidence interval (CI): 28.3%-36.1%] at Wave 1 to 8.7% (95% CI: 6.3%-11.7%) at Wave 6. Risk factors for diarrhea included caregivers alcohol consumption [adjusted odds ratio (AOR) = 1.30; 95% CI: 1.04-1.62], households experiencing three (AOR = 1.78; 95% CI: 1.29-2.45) or four (AOR = 2.58; 95% CI: 1.86-3.58) climatic, biological, economic or conflict shocks in the prior 4 months compared to those experiencing less than 2 shocks, households with moderate (AOR = 1.25; 95% CI: 1.04-1.50) or high (AOR = 1.50; 95% CI: 1.22-1.85) water insecurity in the prior 4 weeks compared to those with no-to-marginal water insecurity, and child wasting (AOR = 1.22; 95% CI: 1.05–1.41).
These findings suggest that multisectoral interventions that reduce alcohol consumption among women, improve access to safe water services, manage malnutrition, and mitigate household shocks could reduce the burden of diarrhea among child under five in this region.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Nawiri Longitudinal Study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) (Award Number: 72DFFP19CA00003). The contents of this paper are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
African Medical and Research Foundation Ethical and Scientific Review Committee (Amref ESRC P905/2020)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data underlying this study will be made available to researchers through the APHRC’s Microdata Portal (https://aphrc.org/microdata-portal/).
